Frank’s topic will be: Taking Combination Products To The Next Level: Combining Advanced Therapies and Medical Devices
The learning objectives for his presentation are:
1. Discuss innovation and concept of Sernova’s cell pouch system in addressing unmet needs in Diabetes, Haemophilia and beyond
2. Review the opportunities and challenges with the development of Combination MedTech products from a Canadian company’s perspective
Frank Shannon is Vice President Clinical Development and Regulatory Affairs at Sernova Corp. Sernova is a regenerative medicine therapeutic technologies company creating long term healthcare solutions.
Frank has a MSc in epidemiology from U of Toronto, working in the pharmaceutical industry since 1992 starting with Ciba-Geigy. He has vast experience in the industry.